Top

Supportive Care in Cancer

Published in:

01-11-2019 | Original Article

Psychosocial distress in oncology: using the distress thermometer for assessing risk classes

Authors: Claudia Cormio, Francesca Caporale, Roberta Spatuzzi, Fulvia Lagattolla, Andrea Lisi, Giusi Graziano

Published in: Supportive Care in Cancer | Issue 11/2019

Abstract

Purpose

Cancer patients often suffer for psychological distress, which can compromise their quality of life. Our study aimed to recognize risk classes for the development of psychosocial distress.

Methods

Three hundred seventy-two adult cancer patients were assessed by the Distress Thermometer (DT) and Problem List at the National Cancer Research Centre “Giovanni Paolo II” of Bari. We also compiled a socio-medical and clinical-medical record survey ad hoc for collecting socio-demographic information and clinical variables. To examine the interplay among the different variables and distinguish internally homogeneous subgroups of patients with diverse risks of distress, the RECursive Partitioning and Amalgamation (RECPAM) technique was used.

Results

Most of patients were female and the most frequent diagnosis was breast cancer, followed by gastro-intestinal cancer and hematological cancer. Distress was present in 43% of the sample, with a total of 156 patients with a DT > 5. The RECPAM analysis identified three distinct and homogeneous patient subgroups (RECPAM classes) with different risks of distress: diagnosis, marital status, and Eastern Cooperative Oncology Group Performance Status.

Conclusion

The use of the distress thermometer allows clinicians to identify patients with certain characteristics that may increase the risk of developing psychosocial distress. This evaluation can allow timely psychological intervention and improve the patient’s therapeutic program.

Zabora J, Brintzenhofeszoc K, Curbow B et al (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28. https://doi.org/10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6 CrossRefPubMed

Vehling S, Koch U, Ladehoff N, Schön G, Wegscheider K, Heckl U, Wels J, Mehnert A (2012) Prävalenz affektiver und Angststörungen bei Krebs: systematischer Literaturreview und Metaanalyse Prevalence of affective and anxiety disorders in cancer: systematic. Psychother Psych Med:249–258

Mehnert A, Vehling S, Sche K et al (2013) Prävalenz von Anpassungsstörung, Akuter und Posttraumati-scher Belastungsstörung sowie somatoformen Störungen bei Krebspatienten Prevalence of adjustment disorder, acute and posttraumatic stress disorders as well as somatoform disorders in cancer patie. Psychother Psych Med 63:466–472. https://doi.org/10.1055/s-0033-1347197 CrossRef

Richardson EM, Schüz N, Sanderson K et al (2017) Illness representations, coping, and illness outcomes in people with cancer: a systematic review and meta-analysis. Psychooncology 26:724–737. https://doi.org/10.1002/pon.4213 CrossRefPubMed

Mitchell AJ, Vahabzadeh A, Magruder K (2011) Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psychooncology 20:572–584. https://doi.org/10.1002/pon.1943 CrossRefPubMed

National Comprehensive Cancer Network Distress management

Kissane D (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 18:1–5. https://doi.org/10.1002/pon.1493 CrossRefPubMed

Bultz BD, Carlson LE (2006) Emotional distress: the sixth vital sign—future directions in cancer care. Psychooncology 15:93–95. https://doi.org/10.1002/pon.1022 CrossRefPubMed

Grassi L, Johansen C, Annunziata MA et al (2013) Screening for distress in cancer patients: a multicenter, nationwide study in Italy. Cancer 119:1714–1721. https://doi.org/10.1002/cncr.27902 CrossRefPubMed

10.

Arnaboldi P, Riva S, Vadilonga V et al (2017) Distress and psychosocial needs in patients accessing a cancer day surgery division: implications for clinical decision making. Front Psychol 7:1–6. https://doi.org/10.3389/fpsyg.2016.02040 CrossRef

11.

Snowden A, C a W, Christie Z et al (2011) The clinical utility of the distress thermometer: a review. Br J Nurs 20:220–227. https://doi.org/10.12968/bjon.2011.20.4.220 CrossRefPubMed

12.

Petty L, Lester J (2014) Distress screening in chronic disease: essential for cancer survivors. J Adv Pract Oncol 5:107–114PubMedPubMedCentral

13.

National Comprehensive Cancer Network (1999) NCCN practice guidelines for the management of psychosocial distress. Oncology (Williston Park) 13:113–147

14.

Roth A, Kornblith A, Batel-Copel L et al (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82:1904–1908CrossRef

15.

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management version 1. 2013

16.

Jacobsen PB, Donovan KA, Trask PC et al (2005) Screening for psychologic distress in ambulatory cancer patients: a multicenter evaluation of the distress thermometer. Cancer 103:1494–1502. https://doi.org/10.1002/cncr.20940 CrossRefPubMed

17.

Donovan KA, Grassi L, McGinty HL, Jacobsen PB (2014) Validation of the distress thermometer worldwide: state of the science. Psychooncology 23:241–250. https://doi.org/10.1002/pon.3430 CrossRefPubMed

18.

Bulli F, Miccinesi G, Maruelli A et al (2009) The measure of psychological distress in cancer patients: the use of distress thermometer in the oncological rehabilitation center of Florence. Support Care Cancer 17:771–779. https://doi.org/10.1007/s00520-008-0543-9 CrossRefPubMed

19.

Dabrowski M, Boucher K, Ward JH et al (2007) Clinical experience with the NCCN distress thermometer in breast cancer patients. J Natl Compr Canc Netw 5:104–111CrossRef

20.

Werner A, Stenner C, Schüz J (2012) Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology 21:818–826. https://doi.org/10.1002/pon.1975 CrossRefPubMed

21.

Carlson LE, Bultz BD (2003) Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 1:8. https://doi.org/10.1186/1477-7525-1-8 CrossRefPubMedPubMedCentral

22.

Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRef

23.

Ciampi A, Hogg S, McKinney S, Thiffault T (1988) RECPAM: a computer program for recursive partition and amalgamation for censored survival data and other situations frequently occurring in biostatistics. I. Methods and program features. Comput Methods Prog Biomed 26:239–256CrossRef

24.

Ciampi A (1992) Constructing prediction trees from data: the RECPAM approach. In: Prague 1991 summer Sch. Comput. Asp. Model choice. Heidelberg: Physica-Verlag, Prague, pp 165–178

25.

Bellè M, Muzzatti B, Tomas M, Gherlinzoni F (2016) Psychological screening of onco-hematologic inpatients: distress thermometer administration. Tumori 102:178–183. https://doi.org/10.5301/tj.5000440 CrossRefPubMed

26.

Meggiolaro E, Berardi MA, Andritsch E et al (2015) Cancer patients’ emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings. Palliat Support Care:1–8. https://doi.org/10.1017/S1478951515000760 CrossRef

27.

Mehnert A, Hartung TJ, Friedrich M et al (2017) One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology. https://doi.org/10.1002/pon.4464 CrossRef

28.

Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141:343–351. https://doi.org/10.1016/j.jad.2012.03.025 CrossRefPubMed

29.

Kurz K, Reißig A, Strauß B, Rosendahl J (2014) Geschlechtsunterschiede in der psychischen Belastung von Patienten mit Lungenkarzinom und deren Partnern. PPmP - Psychother · Psychosom · Medizinische Psychol 64:431–438. https://doi.org/10.1055/s-0034-1375631 CrossRef

30.

Goldzweig G, Andritsch E, Hubert A, Walach N, Perry S, Brenner B, Baider L (2009) How relevant is marital status and gender variables in coping with colorectal cancer? A sample of middle-aged and older cancer survivors. Psychooncology 18:866–874. https://doi.org/10.1002/pon.1499 CrossRefPubMed

31.

Stanton AL, Danoff-Burg S, Cameron CL, Bishop M, Collins CA, Kirk SB, Sworowski LA, Twillman R (2000) Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol 68:875–882CrossRef

32.

Iacorossi L, Gambalunga F, Fabi A et al (2016) Adherence to hormone therapy in women with breast cancer: a quantitative study. Prof Inferm 69:113–121PubMed

33.

Berhili S, Kadiri S, Bouziane A et al (2017) Associated factors with psychological distress in Moroccan breast cancer patients: a cross-sectional study. Breast 31:26–33. https://doi.org/10.1016/j.breast.2016.10.015 CrossRefPubMed

Title: Psychosocial distress in oncology: using the distress thermometer for assessing risk classes
Authors: Claudia Cormio
Francesca Caporale
Roberta Spatuzzi
Fulvia Lagattolla
Andrea Lisi
Giusi Graziano
Publication date: 01-11-2019
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-019-04694-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2019

Patterns and predictors of registration and participation at a supportive care program for prostate cancer survivors

Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice

Exercise on quality of life and cancer-related fatigue for lymphoma survivors: a systematic review and meta-analysis

Who will care for the caregiver? Distress and depression among spousal caregivers of older patients undergoing treatment for cancer

Decision-making in childhood cancer: parents’ and adolescents’ views and perceptions

Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer